Comparative analysis of indicators that determine the effectiveness of the implementation of socio-economic determinants of health in Europe and Ukraine

Kotvitska, А. A.; Volkova, Alina; Korzh, Iuliia; Surikova, I. O.

doi:10.15587/2519-4852.2021.235787

Cited by 6 publications

(5 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Studies by A. Kotvitska et al (2021) and B. Ortiz et al (2018) also confirm that the adoption of modern technologies in agriculture increases production efficiency and yields, which in turn contributes to GDP growth.…”

Section: Discussionmentioning

confidence: 86%

The role of agriculture in shaping the prospects of socio-economic development of Uzbekistan

Muhammedov,

Nizamov,

Mustafoev

et al. 2023

Scientific Horizons

View full text Add to dashboard Cite

The role of agriculture in ensuring food security, creating jobs, and generating export earnings makes it particularly relevant to analyse the impact of this sector on the socio-economic development of the country. The research aims to analyse and assess the impact of agriculture on the socio-economic development of Uzbekistan. To achieve the goal, the indicators of the agricultural sector and socio-economic development from 2013 to 2022 were analysed. It is established that the natural resources of Uzbekistan play a crucial role in the development of agriculture. The analysis of diversified trends in agriculture emphasises the key role of this sector in the socio-economic progress of the country. Despite the variability, the growth in the share of agricultural land and rural population indicates the still high importance of agriculture. However, the decline in value added in the agricultural, forestry and fisheries sectors, as well as the low growth rate of cereal yields, reflects the current challenges in this area. Rising unemployment rates, as well as changes in exports and inflation rates, point to difficulties in the socioeconomic environment. In this light, the prospects for agricultural development as a key agent in improving the socio-economic situation are particularly important. Effective resource management, productivity improvement, job generation, product promotion and expansion of production are all important areas for future development. A strategic approach to agricultural development requires the implementation of complementary measures such as public financial support, mobilisation of investment, use of evaluation ratings and improved public policies. The findings of the study can be used to adapt public policies and programmes in the agricultural sector, as well as to identify priority areas for investment and resources for sustainable economic development

show abstract

Section: Discussionmentioning

confidence: 86%

The role of agriculture in shaping the prospects of socio-economic development of Uzbekistan

Muhammedov,

Nizamov,

Mustafoev

et al. 2023

Scientific Horizons

View full text Add to dashboard Cite

show abstract

“…According to the results of earlier studies of the assortment of antidiabetic medicines by domestic and foreign scientists, it was established that metformin HCL medicines are the most prioritized and available for the pharmacotherapy of type II diabetes among pharmaceuticals of the antidiabetic pharmacological group [19][20][21][22][23][24][25][26][27][28][29][30]. However, considering the constant market changes that affect the availability of these pharmaceuticals on the Ukrainian market, as well as their price, it is relevant to conduct an analysis of the socio-economic indicators of metformin HCL medicines to meet the current needs of patients of various social groups.…”

Section: Discussion Of Research Resultsmentioning

confidence: 99%

Monitoring of indicators of physical availibility and socio-economic affordability of metformin hydrochloride medicines

Ryshchenko

Лыткин

Podolsky

et al. 2022

SR: PS

Self Cite

View full text Add to dashboard Cite

The aim of the study was to monitor the physical availability and socio-economic affordability of metformin hydrochloride medicines, which are used for the treatment of type II diabetes mellitus. Materials and methods. Medical and technological documentation on the standardization of medical care for patients with type II diabetes, data from the State Register of Medicinal Products of Ukraine, software complex “Apteka” of the company “Morion” and data from the pharmaceutical market research analytical company “Pharmstandard” of the company “Morion” were used as research materials to determine indicators of physical availability and socio-economic affordability of metformin HCL medicines for the treatment of type II diabetes. Documentary, analytical methods, the method of marketing research and the method of logical summarization of data were used during the research. Results. According to the results of the analysis of the medical and technological documentation on the standardization of medical care for diabetes mellitus (DM) type II and the State Register of Medicines of Ukraine, a number of characteristics were formed for Metformin HCL pharmaceuticals, namely: tablets or film-coated tablets in a dose of 500 mg, which are manufactured: Ukrainian manufacturers (full cycle of production); Ukrainian manufacturers of tablets in bulk (primary and secondary packaging) and foreign manufacturers. The specified characteristics became the basis for the further selection of several metformin HCL medicines in terms of determining their indicators of physical availability and socio-economic affordability. When determining the physical availability of metformin HCL medications, it was established that Ukrainian-made pharmaceuticals (full production cycle) are presented in the wholesale chain of the pharmaceutical market in full. According to the socio-economic indicator of the solvency adequacy of payment capacity, among the metformin HCL pharmaceuticals, the most economically justified are the Ukrainian-made pharmaceuticals, which are made from tablets in bulk according to the full production cycle. Only 1 medicine was singled out among foreign-made ones, which has the lowest indicator of solvency adequacy for various categories of the population. Conclusions. Monitoring of indicators of physical availability and socio-economic affordability of metformin HCL medicines showed that the most economically justified for able-bodied people and people of retirement age is the use of the Ukrainian-made pharmaceuticals (full cycle and production from tablets in bulk) for the treatment of type II DM)

show abstract

“…The need to provide affordable and effective medical care for patients with dementia in AD against the background of the incurable nature of the development of this pathology creates objective conditions for the development of directions for the rational use of resources directed by the state for the implementation of humanistic principles of the development of society. In Ukraine, the mentioned principles are declared in many legislative and regulatory acts, but the issue of their effective implementation is impossible without considering the relevant international experience [6,29]. The introduction of socially oriented models of care for psychoneurological patients in Ukraine cannot be considered without an analysis of those requirements presented in relevant international documents and clinical guidelines.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of the state of pharmaceutical supply of patients with dementia with Alzheimer disease in Ukraine in accordance with international recommendations

Fedotova

Panfilova

Hala

et al. 2022

SR: PS

View full text Add to dashboard Cite

The aim: to assess the state of pharmaceutical provision of patients with dementia in Alzheimer's disease in Ukraine in accordance with international recommendations. Materials and methods. In our studies, we used data from international guidelines, clinical protocols that regulate the organization of medical and pharmaceutical care for these patients in the USA, Australia, Japan, Germany, Great Britain, Finland, India, Kazakhstan, and Ukraine. The actual state of pharmaceutical provision of these patients in Ukraine was studied using a depersonalized database of medical prescriptions, which operates based on a number of specialized healthcare institutions. In addition, data from the Morion information search system were used. We used general theoretical (historical, formal, graphic, hypothetical-deductive, etc.) and applied (clinical-economic, organizational-economic, mathematical-statistical, etc.) research methods. Results. It has been established that a consolidated opinion has been formed in the world scientific community regarding the possibility of effective use in the pathogenetic treatment of patients with dementia in Alzheimer's disease of drugs from the groups N06DA Acetylcholinesterase inhibitors and N06DX-Other drugs for use in case of dementia. Thus, the pharmaceutical component of international recommendations, clinical protocols for the treatment of patients with dementia in Alzheimer's disease contains four drugs used in pathogenetic therapy. These are N06DA02 Donepezil, N06DA03 Rivastigmine, N06DA04 Galantamine and N06DX01 Memantine. It has been reported that all the above drugs are included in the domestic clinical protocol for the treatment of patients with dementia in Alzheimer's disease, the State Drug Formulary (with the exception of N06DA03 Rivastigmine), and the State Drug Registry. At the same time, all of them were absent from the National List of Essential Drugs, which has an important socio-economic and medical-pharmaceutical significance in the health care system. It was found that patients (200 people) received 2487 prescriptions (100.0 %), among which 9.41 % (234 prescriptions) were drugs used in pathogenetic treatment. There is a highly disproportionate nature of the distribution of prescriptions and consumption by international generic names of drugs. Thus, drugs N06DX01 Memantine accounted for 80.41 % (188 prescriptions) of all prescriptions in the group N06D Drugs for use in dementia, and the consumption rate was UAH 84420.20, which accounted for 91.48 % of the amount of expenses directed to patients with carrying out pathogenetic treatment. Significant dominance of drugs N06DX01 Memantine in the structure of prescriptions and consumption indicates the presence of severe, advanced forms of dementia in patients. This fact once again emphasizes the need for early detection and treatment of cognitive impairment, primarily for the rational use of limited health care resources. We have found that there are no prescriptions for N06D A04 Galantamine preparations, which are recommended by the relevant international recommendations in different countries of the world, as well as by the domestic clinical protocol for the pathogenetic treatment of mild and moderate forms of Alzheimer's disease. At the same time, N06DA05 Ipidacrine preparations were used in the treatment of domestic patients, which are not presented in the pharmaceutical component of international recommendations and protocols governing the pathogenetic treatment of the above-mentioned groups of neuropsychiatric patients. Conclusions. The peculiarities of the formation of the pharmaceutical component in the organization of the treatment process of patients with dementia in Alzheimer's disease in Ukraine, established by us, allow further research on the development of rational ways of resource provision of neuropsychiatric patients

show abstract

Comparative analysis of indicators that determine the effectiveness of the implementation of socio-economic determinants of health in Europe and Ukraine

Cited by 6 publications

References 7 publications

The role of agriculture in shaping the prospects of socio-economic development of Uzbekistan

The role of agriculture in shaping the prospects of socio-economic development of Uzbekistan

Monitoring of indicators of physical availibility and socio-economic affordability of metformin hydrochloride medicines

Evaluation of the state of pharmaceutical supply of patients with dementia with Alzheimer disease in Ukraine in accordance with international recommendations

Contact Info

Product

Resources

About